Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy
Open Access
- 24 May 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 4 (5) , 9228-9234
Abstract
The peptidyl-prolyl isomerase Pin1 is correlated with the progression of cervical cancer via regulating numerous oncogenic and tumor suppressor pathways. p65 is a crucial regulator of tumorigenesis that is regulated by Pin1, and p65 signaling suppression can enhance the antitumor efficacy of doxorubicin (DOX). Here, we utilized a structural mimicry approach to synthesize a series of dibenzothiophene analogues and evaluated their ability to inhibit Pin1 activity. Compound 1a was identified as a potent Pin1 inhibitor that inhibited p65 signaling in vitro and in cervical cancer cells. Moreover, compound 1a enhanced the cytotoxicity of DOX in cervical cancer cells via reducing p65 nuclear accumulation and enhancing DOX uptake. These compounds are promising scaffolds for developing more potent Pin1 inhibitors against cervical cancer, either alone or in combination with anticancer drugs such as DOX.Keywords
Funding Information
- Universidade de Macau (MYRG2016-00151-ICMS-QRCM, MYRG2018-00187-ICMS)
- Health and Medical Research Fund (HMRF/14150561)
- Hong Kong Baptist University (FRG2/17-18/003)
- Natural Science Foundation of Jiangsu Province (BK20150283)
- National Natural Science Foundation of China (21505097, 21575121, 21775131)
- Science and Technology Development Fund, Macao SAR (0072/2018/A2)
- Interdisciplinary Research Clusters Matching Scheme (RC-IRCs/17-18/03)
- SKLEBA and HKBU Strategic Development Fund (SKLP_1718_P04)
- Collaborative Research Fund (C5026-16G)
- Hong Kong Baptist University Century Club Sponsorship Scheme 2018
- Interdisciplinary Research Matching Scheme (RC-IRMS/16-17/03)
This publication has 50 references indexed in Scilit:
- Enzyme inhibition by metal complexes: concepts, strategies and applicationsChemical Science, 2013
- Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteinsTrends in Biochemical Sciences, 2011
- Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesThe FEBS Journal, 2011
- Roles of Sildenafil in Enhancing Drug Sensitivity in CancerCancer Research, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivativesEuropean Journal of Medicinal Chemistry, 2009
- Structural Basis for High-Affinity Peptide Inhibition of Human Pin1ACS Chemical Biology, 2007
- Suppression of MEK/ERK Signaling Pathway Enhances Cisplatin-induced NF-κB Activation by Protein Phosphatase 4-mediated NF-κB p65 Thr DephosphorylationJournal of Biological Chemistry, 2004
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cellsOncogene, 2003